How Estrogen got Crucified!
The Crucifixion
of Estrogen
What if one of the most feared words in women’s health has been discussed too broadly, too emotionally, and too imprecisely?
For decades, millions of women have heard some version of the same warning: “Be careful with estrogen. Estrogen feeds breast cancer.”
For women diagnosed with estrogen-receptor-positive breast cancer, those words can become even more powerful: “My body made the hormone that caused my cancer.”
But what does ER-positive actually mean? Does it mean estrogen itself has been identified as the singular cause of the cancer? Or does it mean the tumor expresses a receptor pathway that can be used therapeutically?
That distinction is the starting point of The Crucifixion of Estrogen, a provocative new book by Richard Nkwenti, R.Ph., Ph.D., MSHS, FAAMFM.
Why this book had to be written
The author’s perspective comes from an unusual intersection of pharmacy, integrative medicine, hormone formulation, laboratory interpretation, and years of listening to both clinicians and patients.
After years of hearing women say they had been warned never to take estrogen because “it causes breast cancer,” a deeper question became impossible to ignore:
ER-positive is not estrogen-positive.
An ER-positive pathology report means that the tumor expresses estrogen-receptor protein at clinically meaningful levels. That information can be enormously important because it helps oncologists identify a pathway that may be vulnerable to treatment.
But identifying a receptor is not the same thing as proving that a particular estrogen molecule initiated the malignancy.
The book carefully separates five concepts that are often blurred together: initiation, promotion, progression, dependency, and therapeutic vulnerability.
The problem with calling everything “estrogen”
Estrogen is not one single molecule. Human physiology includes estradiol, estrone, and estriol. Medicine introduces additional estrogenic compounds such as ethinyl estradiol and conjugated estrogen preparations. Route, dose, metabolism, duration, receptor subtype, and tissue context can all change the biological result.
This does not mean that bioidentical estradiol becomes harmless in an ER-positive tumor. It does not. But it does mean that the word “estrogen” can conceal major pharmacological differences.
Estradiol is not estrone. Estriol is not ethinyl estradiol.
Oral, transdermal, vaginal, and sublingual exposure are not pharmacokinetically identical.
ERα and ERβ do not create one universal biological response.
Healthy tissue, occult disease, established cancer, and survivorship are different clinical states.
Who should read this book?
For clinicians who want stronger language for explaining hormone risk without reducing complex biology to fear.
For those balancing menopause symptoms, endometrial protection, breast risk, and individualized hormone decisions.
For readers interested in how lifesaving endocrine therapy can coexist with more precise language about causation and signaling.
For professionals who understand that molecule, dose, route, metabolism, and formulation are not interchangeable details.
For women who want something more useful than “hormones are dangerous” or “natural hormones are always safe.”
For readers who want to understand why recurrence risk is a different question from cancer initiation—and why caution can still be appropriate.
Ten chapters. One demand: precision.
Women deserve more than fear.
Clinicians deserve more than slogans.
Estrogen should neither be worshipped nor crucified. It should be identified, measured, pharmacologically distinguished, interpreted within receptor biology, and discussed in the context of the individual woman and her disease.
Read the book before repeating the slogan.
The Crucifixion of Estrogen is written for anyone who prescribes hormones, counsels women, treats breast cancer, manages menopause, compounds medications, or wants to understand the science beyond the fear.
GET YOUR COPYIt needed a fair trial.”
Educational notice: This article and the book are intended for educational and informational purposes only. They do not diagnose disease, replace oncology care, or recommend starting, stopping, or changing hormone or cancer treatment without consultation with an appropriately qualified healthcare professional.
